Arizona Tribune - Boulevard

NYSE - LSE

CMSD	0.45%	22	$
BCE	-0.94%	21.31	$
NGG	-2.68%	80.71	$
RIO	-0.87%	94.11	$
BCC	-1.36%	76.59	$
GSK	-2.23%	51.275	$
RYCEF	2.05%	19.5	$
RBGPF	0.93%	65.61	$
JRI	0.05%	12.966	$
RELX	-0.27%	31.585	$
AZN	-2.85%	184.365	$
CMSC	0.87%	21.83	$
BTI	-1.95%	60.58	$
VOD	-1.38%	13.045	$
BP	-1.69%	36.335	$

Featured

Trial begins for suspected mastermind of Malta journalist killing

A Maltese tycoon went on trial on Wednesday accused of ordering the murder of a hard-hitting investigative journalist that rocked the island nation, brought down a government and drew global condemnation.

Traditionalist Catholic society defies Vatican by consecrating new bishops

An ultra-traditionalist breakaway Catholic group consecrated four new bishops on Wednesday in defiance of Pope Leo XIV, who pleaded with them to turn back from what he called a "schismatic act" with Rome.

Last news

InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 11

Purchase of own shares

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk

Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseasesLAB eN² is also expanding, adding Boston Children's Hospital, Boston University, Johns Hopkins University, Joslin Diabetes Center, and the Icahn School of Medicine at Mount Sinai as new participating institutions

Thousands told to flee as wildfire tears through California's Malibu

A ferocious fire tore through Malibu, California, on Tuesday, destroying homes and forcing thousands to evacuate one of the most sought-after areas in the United States.

GM abandons robotaxi operations derailed by accident

US auto giant General Motors announced Tuesday it will abandon its robotaxi development efforts after a highly publicized incident last year stymied its progress in the autonomous vehicle field.

New Syria PM calls for 'stability and calm'

Syria's new transitional prime minister on Tuesday said it was time for "stability and calm" in the country, two days after longtime president Bashar al-Assad was toppled by rebels in a lightning offensive.

NY gunman had manifesto railing against health insurance

The man charged with brazenly gunning down a top health insurance CEO in New York carried a handwritten manifesto of grievances against the industry, police said Tuesday, giving a possible motive for the first time.

US offers $10 mn reward for wanted Chinese hacker

The United States offered a $10 million reward on Tuesday for information leading to the arrest of a Chinese man and co-conspirators wanted for hacking computer firewalls.

Thousands told to flee as wildfire tears through Malibu

A ferocious fire tore through Malibu on Tuesday, destroying homes and forcing thousands to evacuate one of the most sought-after areas in the United States.

NY gunman had manifesto railing against health insurance: police

The man accused of gunning down a health insurance executive in New York was found with a handwritten manifesto laying out complaints against the industry, police said Tuesday, giving a possible motive for the first time.

Wildfire quickly spreads in California's Malibu

A wind-fanned wildfire quickly spread early on Tuesday in Malibu, threatening homes and businesses in the coastal California community where many Hollywood elites reside.

Syria rebels name transitional prime minister

The rebels who ousted president Bashar al-Assad and are now in power in Syria appointed a transitional head of government Tuesday to run the country until March 1, a statement said.

Argentine court drops rape case against French rugby players

An Argentine court on Tuesday dismissed rape charges against two French international rugby players accused of assaulting a woman after playing a match in the country in July.

UN says Israel bombardment of Syria 'must stop'

The UN special envoy for Syria called Tuesday on Israel to halt its military movements and bombardments in Syria, after a war monitor reported 300 air strikes since the fall of president Bashar al-Assad.

Award-winning US poet Nikki Giovanni dies aged 81

Award-winning US poet Nikki Giovanni, who was at the forefront of the Black Arts Movement, died aged 81 after a long battle with cancer, local media reported Tuesday.

Israel's PM Netanyahu in court to testify in corruption trial

Israel's Prime Minister Benjamin Netanyahu arrived in court in Tel Aviv on Tuesday to testify for the first time in his corruption case.

Suspect charged with US insurance chief's murder

A 26-year-old man was arrested and charged with murder Monday in the targeted killing of a health insurance executive on the streets of New York, along with other violations.

Forward Water Technologies Corp Announces Completion of First Trials for the Production of Lithium Carbonate

Forward Water Technologies Corp. (TSXV:FWTC) ("Forward Water" or the "Company") in conjunction with CleanTech Lithium (CTL)(T2)(CTLHF) ("CTL") and Conductive Energy Inc. ("CE") have completed first trials for the production of lithium carbonate from brines sourced in Chile. CTL produced lithium brine eluate from their facilities in Chile and delivered these lithium rich brines to CE's operational site in Chicago, Illinois, USA. CE and FWTC then successfully processed the eluate brine to lithium carbonate using CE's chemical conversion technology and FWTC's proprietary iFOTM process for high strength brine concentration.

Pharmacy Benefit Managers: Driving Cost Savings and Innovation in Healthcare

Real value in working with Canada Drugs Direct as a partner pharmacy that is able to serve as a PBM

World’s largest Psychedelic Church to Close SF Site in Coming Weeks Pastor Cites Harassment from City Planning Department

Zide Door, the psychedelic church garnering national recognition for its devotion to the spiritual power of psilocybin mushrooms, will close its San Francisco location by the end of this year - the victim of a city planning department bent on expelling the institution, Pastor Dave Hodges said Tuesday.Church of Ambrosia, which opened Zide Door April 15, 2023, will continue to serve all 120,000 church members at its founding site in Oakland, he said. The Oakland church showcases an impressive mural and other significant psychedelic art.

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress

Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed at providing comprehensive solutions for patients with obstructive sleep apnea (OSA) and associated oxidative stress. This collaboration combines Vivos Therapeutics' FDA-cleared oral medical devices for treating moderate to severe OSA in children and adults with Cellev8 Nutrition's proprietary gummy form of nutraceuticals featuring the powerful enzymatic antioxidant, SOD2, designed to mitigate oxidative stress in the body.

Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN

Admission of New Ordinary Shares and New ISIN

DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

MMJ Submits FDA Investigational New Drug Application for Cannabis-Derived Drug

Tallahassee Plastic Surgery Clinic Launches Nouvo Med Spa - Area's Newest Destination in Non-Invasive Aesthetic Care

Tallahassee Plastic Surgery Clinic has introduced Nouvo Med Spa, an advanced medical spa offering cutting-edge non-surgical aesthetic treatments under the guidance of the clinic's experienced plastic surgeons. Located at 2458 Mahan Drive, Suite 103, Nouvo Med Spa offers non-invasive cosmetic and aesthetic services in a modern, inviting setting as a complement to the services offered by Tallahassee Plastic Surgery Clinic.

Dolphin Entertainment Embarks on an Inspiring Journey to Adapt Clare Mulley's Award-Winning Debut Biography the Woman Who Saved the Children Into a Feature Film

Dolphin Entertainment (NASDAQ:DLPN) proudly announces its latest scripted content project with the acquisition of rights to The Woman Who Saved the Children, an acclaimed biography by award-winning author Clare Mulley. The book, which chronicles the extraordinary life of humanitarian trailblazer Eglantyne Jebb, will be brought to life as a feature film under Dolphin's production banner.

Dr. Amir Bajoghli and Team Publish New Case Study on Aquagenic Urticaria in BMJ Journals

Dr. Amir Bajoghli and his colleagues have recently published an insightful case study in BMJ Journals, titled "Aquagenic Urticaria in an Adolescent: Differential Diagnosis and Management." The study examines a rare case of aquagenic urticaria and underscores the importance of accurate diagnosis and effective management strategies for this unusual condition.

Noble Roman's Announces Additional Growth

Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announced the continued rapid expansion of its non-traditional franchises, primarily in convenience stores and travel plazas. According to the company's current opening schedule, it will open approximately 19 new franchise locations in the fourth quarter of 2024, which includes three new units for Majors Management LLC. As the numbers indicate, the company maintains an extremely diversified sales and new unit pipeline in addition to the multi-unit Majors Management development agreement. With the additional new unit openings in the 4th quarter, the company expects a total of approximately 70 new unit openings in 2024. In addition, the company is building a significant backlog of new units to open in the first quarter of 2025, including several more Majors Management locations.

Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne

- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne -- Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 study for the treatment of acne and expects to announce topline results in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -

Taiwan SAKURA Introduces Advanced Kitchen Solutions for Healthier Living

Invisible threats like kitchen fumes pose serious risks to your family's health, but now there's a solution. Taiwan SAKURA M6000 wall-mount chimney range hood is designed to tackle these challenges with cutting-edge technology, offering powerful smoke capture and efficient filtration to keep your kitchen fresh and your family safe. With its sleek design and advanced features, it redefines what a modern kitchen should be.

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End

Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain

Ignite Biomedical Achieves Key Milestone in Precision Medicine with Successful Analytical Validation of TNF-alpha Inhibitor Treatment Response Predictor

Validation Results Pave the Way for Clinical Studies Focused on Transforming Patient Outcomes inInflammatory BowelDisease

Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product

~ Supply Chain Now Fully Secure for PF614-MPAR ~

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd., that the safety review committee recommends commencing dosing of the second cohort in its trial entitled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants." The safety review committee made this recommendation after reviewing safety and pharmacokinetic data from participants in the first cohort.

Arizona Tribune - Boulevard (English)